SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-017629
Filing Date
2024-05-03
Accepted
2024-05-03 08:00:32
Documents
15
Period of Report
2024-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63076
2 ex10-1.htm EX-10.1 482489
3 ex10-2.htm EX-10.2 157016
  Complete submission text file 0001493152-24-017629.txt   1012271

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sonn-20240502.xsd EX-101.SCH 3018
5 XBRL LABEL FILE sonn-20240502_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE sonn-20240502_pre.xml EX-101.PRE 22361
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3710
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 24910828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)